Clinical trials: Gender Dysphoria
Speech Therapy, Transgender Women
Voice Feminisation in Transgender Women
The voice is a reflection of our identity. In the case of transgender women, there may be a gap between perceived male voice and female appearance.
- Conditions
- Speech Therapy, Transgender Women, Gender Dysphoria
- Trial name
- FemVoc (NCT03899896)
- Where
- France
- Volunteers
- 77 people
- Sponsor
- Central Hospital, Nancy, France
HIV/AIDS, STI
Transgender Cohort Study of Gender Affirmation and HIV-related Health
This observational research study will evaluate medical gender affirmation delivered in primary care as an intervention to reduce disparities in HIV-related outcomes (e.g., low rates of PrEP uptake for HIV-uninfected patients…
- Conditions
- HIV/AIDS, STI, Gender Dysphoria, Transsexualism
- Trial name
- NCT03595956
- Testing
- Medical gender affirmation
- Where
- United States
- Volunteers
- 4,500 people, healthy volunteers welcome
- Sponsor
- Fenway Community Health
Gender Dysphoria, Gender Identity
Early Mental Response - The EMRE Study
Primary question: Does transgender men's experience of gender incongruence improve within 6 weeks of hormonal treatment compared to placebo? Long before any bodily changes occur.
- Conditions
- Gender Dysphoria, Gender Identity, Gender Issues
- Trial name
- EMRE (NCT05649605)
- Testing
- Testosterone treatment
- Where
- Sweden
- Volunteers
- 70 people
- Sponsor
- Karolinska University Hospital
Gender Dysphoria, Opioid Use
The Effect of Pectoral Blocks on Perioperative Pain in Gender Affirmation Top Surgery
Despite recent advancements with regional and local anesthesia, postoperative pain continues to be a major concern for patients undergoing breast surgery.
- Conditions
- Gender Dysphoria, Opioid Use, Pain, Postoperative
- Trial name
- NCT04474366
- Testing
- Ropivacaine 0.2% Injectable Solution, Saline (0.9%)
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- University of California, San Francisco
Gender Dysphoria
Polyethylene-glycol Assisted Nerve Repair in Phalloplasty
Phalloplasty, a genitourinary surgery for transmasculine patients, reconstructs a neophallus using tissue transferred from other parts of the body to the groin.
- Trial name
- NCT05897086
- Testing
- Polyethylene Glycol 3350
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Vanderbilt University Medical Center
Transgender Women, Voice Alteration
Gender-affirming Voice Training With Visual Feedback
The goal of this clinical trial is to learn if prototype software can be used to train vocal pitch and resonance in trans women.
- Trial name
- NCT07017595
- Testing
- Visual-acoustic biofeedback: experimental
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- University of Cincinnati
Gender Incongruence, Cardiovascular (CV) Risk
Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway
Gender incongruence, now classified in ICD-11 as a "marked and persistent incongruence between an individual's experienced gender and the gender assigned at birth," is managed in dedicated, multidisciplinary centres that…
- Conditions
- Gender Incongruence, Cardiovascular (CV) Risk, Cardiovascular Disease Risk Factor, Cardiovascular Disease Acute
- Trial name
- CV-TGD (NCT07187947)
- Testing
- Feminizing GAHT, Masculinizing GAHT
- Where
- Italy
- Volunteers
- 500 people
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
Gender Dysphoria, Hormone Therapy Induced Morphologic Change
Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content
Background: Gender affirming hormone therapy (GAHT) leads to profound changes in sex hormone levels, carrying a wide range of implications for major physiological processes in the body.
- Trial name
- NCT06291675
- Testing
- gender-affirming hormone therapy
- Where
- Austria
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Medical University of Vienna
Postoperative Bleeding, Gender Dysphoria
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
The purpose of this study is to determine if applying a single dose of topical estrogen cream in the operating room at the end of your hysterectomy (removal of uterus and cervix) improves the postoperative experience with…
- Conditions
- Postoperative Bleeding, Gender Dysphoria, Hysterectomy
- Trial name
- NCT06969326
- Testing
- Use of topical estradiol, No intervention
- Where
- United States
- Volunteers
- 48 people
- Sponsor
- Women and Infants Hospital of Rhode Island
Gender Dysphoria, Gender Dysphoria, Adult
Metoidioplasty and Phalloplasty Surgery Decision Making
The goal of this clinical trial is to test a new online tool designed to provide clear and understandable information to help individuals considering Metoidioplasty and Phalloplasty Surgeries (MaPS) make informed decisions The…
- Conditions
- Gender Dysphoria, Gender Dysphoria, Adult, Gender Incongruence, Transgenderism
- Trial name
- MaPS (NCT06565663)
- Testing
- MaPS Decision Aid
- Where
- 2 sites in United States
- Volunteers
- 140 people
- Sponsor
- Dartmouth-Hitchcock Medical Center
Gender Dysphoria
Evaluation of the Effectiveness of Hormonal Treatment in Adolescents Suffering From Gender Dysphoria
Gender dysphoria (GD) is a significant suffering lasting more than 6 months in a subject, with regard to the discrepancy felt between his or her gender identity and his or her birth sex.
- Trial name
- TRANSADO (NCT06351501)
- Testing
- hormonal treatment with cross sex hormones (testosterone or oestrogenes) started at 14 years old +/- 6 months, Cross sex hormones ( œstrogenes or testosterone) started at 15.5 years old +/- 6 months
- Where
- 4 sites in France
- Volunteers
- 60 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Gender Dysphoria
Effect of Nitropaste in Chest Masculinizing Surgery
Nitropaste is a topical agent that contains 2% nitroglycerin. It is an effective vascular smooth dilator, with more powerful effect on venous vasculature than arterial vasculature.
- Trial name
- NCT06428669
- Testing
- Nitro-Bid 2 % Topical Ointment
- Where
- United States
- Volunteers
- 256 people
- Sponsor
- University of Virginia
Rokitansky Kuster Hauser Syndrome, Vaginal Neoplasms
Peritoneum Vaginoplasty; Implementation According to IDEAL Framework
This study aims to assess if a single flap peritoneum vaginoplasty is safe and feasible.The IDEAL framework for evaluation and implementation of surgical techniques will be used.
- Conditions
- Rokitansky Kuster Hauser Syndrome, Vaginal Neoplasms, Gender Incongruence, Vaginal Obstruction
- Trial name
- PeriVaS (NCT05925361)
- Testing
- Laparoscopic pedicled single flap peritoneum vaginoplasty
- Where
- Netherlands
- Volunteers
- 13 people
- Sponsor
- Amsterdam UMC, location VUmc
Gender Dysphoria
Patient Reported Outcome on Genital Sensitivity and Sexual Function After Genital Gender Affirming Surgery
For genital gender affirming surgery, it remains unclear to what extent genital sensitivity might be expected and what the impact of this might be on sexual functioning.
- Trial name
- PROGAS (NCT04993469)
- Testing
- Semmes-Weinstein monofilament testing and questionnaires
- Where
- Belgium
- Volunteers
- 200 people
- Sponsor
- University Hospital, Ghent
Fertility Preservation, Parenting
Fertility Desires and Reproductive Needs of Transgender People
Majority of transgender and gender nonconforming people seeking medical care are in pubertal and reproductive age. Cross-sex hormones may compromise fertility especially when preceded by puberty blocking regimen.
- Conditions
- Fertility Preservation, Parenting, Gender Dysphoria
- Trial name
- PaFer (NCT03836027)
- Testing
- No intervention
- Where
- France
- Volunteers
- 100 people
- Sponsor
- Central Hospital, Nancy, France
Gender Dysphoria
Developmental Correlates and Hormone Therapy Effects in Gender Dysphoria
The aim of the research is to study longitudinally the effects of reassignment hormonotherapy on the connectome of MtF (biological men who are transitioning to the female gender) dysphoric subjects after 6 months of hormone…
- Trial name
- DCHGD (NCT04309760)
- Testing
- MRI
- Volunteers
- healthy volunteers welcome
- Sponsor
- Hôpital le Vinatier
Gender Dysphoria, Adolescent
Fertility Preservation for Transfeminine Adolescents Via Semen Cryopreservation or Testicular Sperm Extraction
The goal of this observational cohort study is to identify and predict parameters for successful testicular sperm extraction (TESE) procedures or semen cryopreservation more accurately and to evaluate the decision making process…
- Trial name
- TESE (NCT06400199)
- Where
- 2 sites in Netherlands
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Amsterdam UMC, location VUmc
Gender Dysphoria in Adolescents and Adults
Transgender Therapeutic Support Groups
This study seeks to explore the effects for transgender people undergoing surgical interventions of participating in pre/post-surgical therapeutic support groups in order to assess the value of adding these programs to hospital…
- Trial name
- NCT04217707
- Testing
- Pre- and Post-Surgical Transgender Therapeutic Support Group
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- Denver Health and Hospital Authority
Transgenderism, Gender Dysphoria
Effectiveness of Speech Therapy in Trans Women.
One of the greatest hurdles in the transition of transgender persons is that voice, speech and communication are not congruent with the desired gender.
- Conditions
- Transgenderism, Gender Dysphoria, Speech Therapy, Voice Disorder Due to Transsexualism
- Trial name
- NCT04708600
- Testing
- Pitch Elevation Therapy, Articulation Resonance Therapy
- Where
- Belgium
- Volunteers
- 78 people, healthy volunteers welcome
- Sponsor
- University Ghent
Gender Dysphoria
Understanding Perceived Access and Receipt of Gender-affirming Treatments Among Transgender Veterans
Transgender Veterans (trans Vets) frequently experience gender dysphoria or distress related to discord between their gender identity and birth sex.
- Trial name
- NCT06615401
- Where
- United States
- Volunteers
- 986 people, healthy volunteers welcome
- Sponsor
- VA Office of Research and Development